Development of New Organotin Anti-Tumor Drugs
Author Information
Author(s): Dick de Vos, Rudolph Willem, Marcel Gielen, Kyra E. van Wingerden, Kees Nooter
Primary Institution: Medical Department, Pharmachemie BV
Hypothesis
Can organotin derivatives be developed as effective anti-tumor drugs?
Conclusion
Organotin compounds show promising anti-tumor activity, but their poor water solubility limits their in vivo effectiveness.
Supporting Evidence
- Organotin compounds have shown high in vitro activity, sometimes comparable to doxorubicin.
- Testing revealed that the presence of polar substituents can improve water solubility.
- Neurotoxicity and gastrointestinal toxicity were observed among the organotin derivatives.
Takeaway
Scientists are trying to create new cancer-fighting medicines from organotin compounds, but they have trouble because these medicines don't dissolve well in water.
Methodology
The study involved in vitro testing on human tumor cell lines and in vivo testing in murine models.
Limitations
The main limitation is the poor water solubility of the organotin compounds, affecting their in vivo testing.
Participant Demographics
10-12 week old female Balb/c mice were used for in vivo testing.
Want to read the original?
Access the complete publication on the publisher's website